SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-009242
Filing Date
2018-11-13
Accepted
2018-11-13 09:28:17
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ymab-20180930x10q.htm 10-Q 1719037
2 EX-31.1 ymab-20180930ex311abc6c2.htm EX-31.1 20156
3 EX-31.2 ymab-20180930ex31216c6df.htm EX-31.2 20053
4 EX-32.1 ymab-20180930ex321f341a8.htm EX-32.1 9824
5 EX-32.2 ymab-20180930ex322381815.htm EX-32.2 9781
  Complete submission text file 0001558370-18-009242.txt   4415512

Data Files

Seq Description Document Type Size
6 EX-101.INS ymab-20180930.xml EX-101.INS 504173
7 EX-101.SCH ymab-20180930.xsd EX-101.SCH 48257
8 EX-101.CAL ymab-20180930_cal.xml EX-101.CAL 26551
9 EX-101.DEF ymab-20180930_def.xml EX-101.DEF 135945
10 EX-101.LAB ymab-20180930_lab.xml EX-101.LAB 335783
11 EX-101.PRE ymab-20180930_pre.xml EX-101.PRE 279115
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38650 | Film No.: 181175655
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1